Tag: Stem cells
Future Perspectives: Implementation of Artificial Intelligence in Umbilical Cord Biobanking
Introduction
The incorporation and implementation of Artificial Intelligence (AI) into Umbilical cord biobanking is still at its developing stage, but there is a great potential...
Abu Dhabi Biobank Launched by DoH and M42 Features the Region’s Largest Hybrid Cord...
Highlights
The Abu Dhabi Biobank, launched by DoH and M42, introduces the region’s largest hybrid cord blood bank.
The initiative aims to improve treatment...
Stem Cell Storage Partnership Between LMRUK and Smart Cells International Can be a Life...
Leukaemia & Myeloma Research UK (LMRUK) and Smart Cells International, the UK's first private stem cell storage company, have collaborated to procure, process and...
Stanford CVI Biobank: A Growing Library of Human iPSC Lines for Cardiovascular Research
Banking has been around for more than 4,000 years and involves saving and lending resources for personal and communal benefits. Biobanking, on the other...
Lineage Cell Therapeutics Issued US Patent For Antigen Presenting Dendritic Cell Production System
Lineage Cell Therapeutics, Inc., a clinical-stage
biotechnology company developing novel cell therapies for unmet medical needs, has
announced that the United States Patent and Trademark Office...
Americord Registry Launches Amniotic Membrane Biobanking, New Product
Americord Registry has launched its newest stem cell banking
product, Placental Tissue 2.0™. Americord was one of the first family cord
blood banks to store placental...
Be The Match® And Gift Of Life® Marrow Registry To Open Blood Stem Cell...
Be The Match® and Gift of Life® Marrow Registry, intend to open, in
late July, the first registry-operated blood stem cell collection facility in
Boca Raton,...
TreeFrog Therapeutics Raises $7.8M To Develop C-Stem™ 3D Stem Cell Culture In Multiple Indications
TreeFrog Therapeutics, an expert stem cell company, has
raised €7.1M (USD $7.8M) in a Series A funding round. The proceeds will be used
to transition the...
FDA Grants RMAT To ExCellThera’s Cell Expansion Technology
ExCellThera Inc., an advanced clinical stage biotechnology
company delivering molecules and bioengineering solutions to expand stem and
immune cells for therapeutic use, has announced that the...
BrainStorm Cell Therapeutics Contracts Cleveland Clinic For Multiple Sclerosis Clinical Trial Site
BrainStorm Cell Therapeutics Inc., has announced that the Cleveland Clinic is the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter...



















